Association of Diabetes Care & Education Specialists

Login
Home Page
Your Personalized Guide
to AADE Resources
AADE GPS
My Profile
My Memberships
My Purchases
MY AADE NETWORK
My Open Invoices
Join Online
Online Store
Events
Make a Donation
Access My Learning
Access AADE7 System
Find a Diabetes Educator
Find an Accredited DSME Program
Apply For/Manage My DEAP Application
Choose Your Diabetes Treatment Adventure: Clinical Decision Points Using GLP-1 Receptor Agonists

Choose Your Diabetes Treatment Adventure: Clinical Decision Points Using GLP-1 Receptor Agonists

Quick Overview
(DISCONTINUED) View the recording of this 90-minute corporate symposium. ...
Cart
My Cart
Availability: In stock

Price: 0.00
Required
Description

Choose Your Diabetes Treatment Adventure: Clinical Decision Points Using GLP-1 Receptor Agonists

Recorded Corporate Symposium
Effective dates for CE credit: 8/8/14 - 8/8/16
FREE to AADE Members

Program Overview

In recent years the landscape of GLP-1 receptor agonists (RAs) has become decidedly more complex, and this trend will continue in the foreseeable future as more agents are approved. As the number of therapy choices increase, patients now have the option to change from one agent to another; also, as weekly-dosing regimens are approved, patients may prefer to discontinue daily therapy in favor of a more convenient schedule. This case-based presentation will employ a highly interactive, virtual practice environment format, allowing the audience to “choose their diabetes adventure”, engaging CDEs in real-world practical strategies and clinical pearls on use of GLP-1 RAs.

The purpose of this activity is to cescribe new methodologies used to support and enhance the quality of patient centered care and demonstrate how to enhance the role of the diabetes educator in a time of innovative change.

Activity Type:

This recording of an online presentation is a knowledge-based learning activity.

Learning Objectives

At the end of this presentation, the participant will be able to:

- Evaluate the latest data regarding available and emerging GLP-1 agonists, including mechanism, glycemic and nonglycemic benefits, and safety and tolerability data
- Appraise current recommendations for the treatment of type 2 diabetes, focusing on individualizing treatment goals and strategies using GLP-1 receptor agonists with respect to pharmacologic differences between agents and patient specific factors
- Develop comprehensive, individualized treatment strategies for patients with type 2 diabetes focusing on key education and counseling points for patients who are beginning GLP-1 agonist therapy, switching between one GLP-1 agonist to another, or adding GLP-1 agonist therapy to an existing treatment regimen

Intended Audience

This is a knowledge-based activity designed for individual or groups of diabetes educators, including RNs, RDs, Pharmacists, Nurse Practitioners, Clinical Nurse Specialists, Physician Assistants, MDs, and other health care providers interested in staying up to date on current practices of care for their patients with diabetes and other related conditions.

Faculty

Joe F. Largay, PA-C, CDE
Clinical Instructor, Department of Medicine
Division of Endocrinology, Diabetes Care Center
Director, Clinical Trials Program
University of North Carolina
Chapel Hill, NC

Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC
The Diabetes Institute
Walter Reed National Military Medical Center
Adjunct Assistant Professor
Uniformed Services University of the Health Sciences
Bethesda, MD

Geralyn R. Spollett, MSN, ANP, CDE
Adult Nurse Practitioner
Associate Director
Yale Diabetes Center
New Haven, CT

Support

This program is supported by an unrestricted educational grant from Lilly.

Continuing Education Credit

This educational program will provide 1.5 contact hours of continuing education credit.

Accreditation Information

Registered Nurses

The American Association of Diabetes Educators is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This educational program will provide 1.5 contact hours of continuing education credit.

AADE is accredited as a provider of continuing nursing education by the California Board of Registered Nursing (CEP # 10977).

Registered Dietitians

The American Association of Diabetes Educators, (AM001) is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR). Registered dietitians (RDs) and dietetic technicians, registered (DTRs) will receive 1.5 continuing professional education units (CPEUs) for completion of this program. Continuing Professional Education Provider Accreditation does not constitute endorsement by CDR of a provider, program, or materials.

Registered Pharmacists

The American Association of Diabetes Educators is accredited bythe Accreditation Council for Pharmacy Education as a provider of continuingpharmacy education.  This programprovides 1.5 contact hours (0.15 CEUs) of continuing education credit.

ACPE Universal Program Number: 0069-9999-14-205-H01-P
Effective Dates: 8/8/2014 – 8/8/2016

Faculty Disclosures

It is the policy of the American Association of Diabetes Educators to require that anyone who has an opportunity to affect continuing education activities content (e.g. authors, presenters and program planners) with products or services from a commercial interest with which s/he has financial relationships, discloses those financial relationship/s with commercial entities to participants.

Disclosure of a relationship is not intended to suggest or condone bias in any presentation, but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Relevant disclosures (or lack thereof) among educational activity faculty and planners are as follows:
- Joe F. Largay, PA-C, CDE has disclosed that he is a consultant for sanofi-aventis, Takeda, Valeritas, and Vivus. He receives grant/research support from Amylin, Andromeda, Boehringer-Ingelheim, GI Dynamics, Halozyme, Hoffman-La Roche, Immune Tolerance Network, Jaeb Center for Health Research, Inc., Johnson and Johnson, Lexicon, Lilly, Medtronic, Merck, Novo Nordisk, Orexigen, Phase Bio, NIH/NHLBI, sanofi-aventis, and Tolerx.
- Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC, has no relevant financial disclosures to report.
- Geralyn R. Spollett, MSN, ANP, CDE has disclosed that she is a consultant for Lilly and sanofi-aventis and she is a member of the speakers’ bureau for sanofi-aventis.
- Ashley C. Lilley, Account Director, Creative Educational Concepts, Inc., has no relevant financial disclosures to report.
- Nancy Stonis, AADE, Chicago, IL, has no relevant financial disclosures to report.

The approval of this educational offering by the AADE does not imply endorsement of specific therapies, treatments, or products discussed in the presentations.

Originally presented on: 8/8/2014
Expiration date: 8/8/2016

Access Period

You will have access to this learning activity for a period of six months after you enroll, or whenever the activity's CE credits expire (whichever comes first).

Price

AADE Members: FREE
Non-Members: $45.00


We're sorry, but there is no inventory for the product you selected. Check out these other great products:

Related Items

    Products Others Bought

      Reviews
      No records found.